Clinical and pathological characteristics of thin cutaneous melanomas with rapid recurrence.
Bhave, P.; Wong, T.; Margolin, K.; Hoeijmakers, L.; Mangana, J.; Vitale, M. G.; Ascierto, P. A.; Maurichi, A.; Santinami, M.; Heddle, G.; Allayous, C.; Lebbe, C.; Kattak, A.; Forchhammer, S.; Kessels, J. I.; Lau, P.; Lo, S. N.; Papenfuss, A. A.; McArthur, G. A.
Show abstract
Background: Although thin, T1 melanomas have an excellent cure rate with surgery alone, >25% of melanoma deaths originate from thin melanomas (TMs). There is, therefore, an urgent need to improve the identification and management of patients with TMs at high risk of recurrence. Methods: Patients with T1 melanoma and recurrence [≤] 2 years of diagnosis (T1 rapid group) were compared to patients with T1 melanoma and recurrence [≥]10 years after diagnosis (T1 late group). Results: 442 patients from 14 sites were included: 310 and 132 patients in the T1 rapid and late groups, respectively. Median age at primary melanoma diagnosis was 51 years [15-85], 272 (62%) male, 254 (58%) superficial spreading and 101 (23%) head/neck primary. The majority (73%) of recurrences in the T1 rapid group were locoregional. Using univariable logistic regression analysis, age >65 years (p<0.0001), lentigo maligna (LM) melanoma subtype (p=0.025), head/neck primary site (p=0.0065), mitoses [≥]1/mm2 (p=0.0181) and ulceration (p=0.0087) were significantly associated with T1 rapid recurrence compared to T1 late recurrence. Using multivariable analysis, age >65 years (p=0.0010), mitoses [≥]1/mm2 (p=0.049) and ulceration (p=0.037) remained significant. Conclusions: Rapid recurrence of TM is associated with age >65 years, LM subtype, head/neck primary site, mitoses [≥]1/mm2 and ulceration.
Matching journals
The top 7 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Hotspot KRAS mutations in brain metastases at the first metastatic recurrence of cutaneous melanoma 93%
- Checkpoint-blocker induced autoimmunity is associated with pretreatment T cell expression profiles and favourable outcome in melanoma 91%
- Ovarian carcinosarcoma is a distinct form of ovarian cancer with poorer survival compared to tubo-ovarian high grade serous carcinoma 87%
Similar papers in this journal
Similar papers in this journal
- Development of a Metastatic Uveal Melanoma Prognostic risk Score (MUMPS) for use in patients receiving immune checkpoint inhibitors 93%
- Capacity for compensatory cyclin D2 response confers trametinib resistance in canine mucosal melanoma 91%
- The clinical, genomic, and transcriptomic landscape of BRAF mutant cancers 90%
Similar papers in this journal
- CD38hiCD19dim cells in lymph nodes predict favorable prognosis in patients with stage III melanoma receiving adjuvant PD-1-blockade 93%
- Alpha-synuclein knockout impairs melanoma development and alters DNA damage repair in the TG3 mouse model in a sex-dependent manner 88%
- Meta-Analysis of Adenoviral p53 Gene Therapy Clinical Trials in Recurrent Head and Neck Squamous Cell Carcinoma 88%
Similar papers in this journal
- Explainable machine learning identifies features and thresholds predictive of immunotherapy response 92%
- Matched three-dimensional organoids and two-dimensional cell lines of melanoma brain metastases mirror response to targeted molecular therapy 92%
- Quantifying innervation facilitated by deep learning in wound healing 89%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.